Sentara Health pilots GW RhythmX's AI precision care platform to support emerging primary care models
Not-for-profit health system Sentara Health is moving beyond administrative automation to test artificial intelligence-powered clinical care directly during primary care visits.
Ayble Health has successfully raised $16 million in a oversubscribed series A funding round to expand its AI-driven precision digestive and autoimmune healthcare services. The investment was led by Neon, with support from Unum Ventures, Upfront Ventures, M13, Cleveland Clinic Ventures, DigiTx, Accomplice, and numerous individual investors.
Kimmy Scotti, a founding and managing partner at Neon, expressed admiration for Ayble's work, stating, "I've been tracking the GI space closely for years, and what Ayble has built is different."
The company's success can be attributed to its combination of specialized clinical expertise and advanced technology. Ayble Health aims to leverage the funding to further develop its AI and clinician precision care model, as well as enhance its data-driven personalization for patient engagement, enrollment, and care. In addition to its focus on gastrointestinal (GI) conditions, the company plans to extend its services to autoimmune conditions.
Ayble Health's rapid growth has been notable, with Amazon Health's Benefits Connector selecting it as the first digital gastrointestinal (GI) solution. The company is currently in-network with most commercial health plans, covering over 80 million patients through various partnerships, including Mayo Clinic, Cleveland Clinic, Priority Health, Castlight Health, and others.
Sam Jactel, Ayble Health's founder and CEO, shared the motivation behind the company's establishment. As an Inflammatory Bowel Disease patient, Jactel has experienced diagnostic delays, care gaps, and the frustration of a system not designed for patients who require ongoing, coordinated care. He emphasized that many patients are also managing autoimmune conditions, and the need for a comprehensive approach is evident.
With this funding, Ayble aims to address this gap by deepening its AI precision care capabilities and expanding its multidisciplinary model to encompass autoimmune conditions as well.
Written by urgent.news from Fierce Healthcare's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
